超级碰在线-超级碰碰永久免费视频播放-超级碰碰碰免费视频播放-超级碰碰碰免费视频-亚洲国产99在线精品一区69堂-亚洲高清资源在线观看

美國 NeuroSigma  
位于加利福尼亞州洛杉磯市的NeuroSigma公司的新產(chǎn)品——Monarch外部三叉神經(jīng)激發(fā)(eTNS)系統(tǒng)已經(jīng)通過歐盟批準(zhǔn)。在產(chǎn)品發(fā)布會上，該公司把它被定義為9歲及以上癲癇和抑郁癥患者的輔助治療系統(tǒng)。

NeuroSigma, Inc. is a medical device company based in Westwood, California. NeuroSigma has a growing pipeline of treatments targeting epilepsy, depression, post-traumatic stress disorder (PTSD), obesity, among others and is actively engaged in cutting-edge preclinical research and development, as well as groundbreaking Phase I and Phase II clinical trials. NeuroSigma is utilizing two distinct therapy platforms:

Deep Brain Stimulation (DBS) - Pioneered in France for the treatment of essential tremor and Parkinson’s disease. New therapies in development by NeuroSigma.

Trigeminal Nerve Stimulation (TNS) - A proprietary therapy developed at the University of California, Los Angeles and exclusively licensed to NeuroSigma.

CAUTION: The TNS and DBS therapies being developed by NeuroSigma are investigational therapies and limited by United States law for investigational use.